Last reviewed · How we verify

total intravenous anaesthesia with Propofol.

Centre Hospitalier Universitaire Dijon · FDA-approved active Small molecule

total intravenous anaesthesia with Propofol. is a Intravenous sedative-hypnotic Small molecule drug developed by Centre Hospitalier Universitaire Dijon. It is currently FDA-approved for Induction of general anesthesia in adults and children, Maintenance of general anesthesia via continuous infusion, Sedation of intubated patients in intensive care units.

Propofol is a rapid-acting intravenous sedative-hypnotic that enhances inhibitory GABA neurotransmission in the central nervous system to produce unconsciousness and anesthesia.

Propofol is a rapid-acting intravenous sedative-hypnotic that enhances inhibitory GABA neurotransmission in the central nervous system to produce unconsciousness and anesthesia. Used for Induction of general anesthesia in adults and children, Maintenance of general anesthesia via continuous infusion, Sedation of intubated patients in intensive care units.

At a glance

Generic nametotal intravenous anaesthesia with Propofol.
SponsorCentre Hospitalier Universitaire Dijon
Drug classIntravenous sedative-hypnotic
TargetGABA-A receptor
ModalitySmall molecule
Therapeutic areaAnesthesiology
PhaseFDA-approved

Mechanism of action

Propofol acts as a positive allosteric modulator of GABA-A receptors, increasing chloride ion influx and neuronal hyperpolarization. This results in rapid onset of sedation and unconsciousness suitable for induction and maintenance of general anesthesia. Total intravenous anesthesia (TIVA) with propofol provides continuous IV infusion for complete anesthetic management without volatile agents.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about total intravenous anaesthesia with Propofol.

What is total intravenous anaesthesia with Propofol.?

total intravenous anaesthesia with Propofol. is a Intravenous sedative-hypnotic drug developed by Centre Hospitalier Universitaire Dijon, indicated for Induction of general anesthesia in adults and children, Maintenance of general anesthesia via continuous infusion, Sedation of intubated patients in intensive care units.

How does total intravenous anaesthesia with Propofol. work?

Propofol is a rapid-acting intravenous sedative-hypnotic that enhances inhibitory GABA neurotransmission in the central nervous system to produce unconsciousness and anesthesia.

What is total intravenous anaesthesia with Propofol. used for?

total intravenous anaesthesia with Propofol. is indicated for Induction of general anesthesia in adults and children, Maintenance of general anesthesia via continuous infusion, Sedation of intubated patients in intensive care units.

Who makes total intravenous anaesthesia with Propofol.?

total intravenous anaesthesia with Propofol. is developed and marketed by Centre Hospitalier Universitaire Dijon (see full Centre Hospitalier Universitaire Dijon pipeline at /company/centre-hospitalier-universitaire-dijon).

What drug class is total intravenous anaesthesia with Propofol. in?

total intravenous anaesthesia with Propofol. belongs to the Intravenous sedative-hypnotic class. See all Intravenous sedative-hypnotic drugs at /class/intravenous-sedative-hypnotic.

What development phase is total intravenous anaesthesia with Propofol. in?

total intravenous anaesthesia with Propofol. is FDA-approved (marketed).

What are the side effects of total intravenous anaesthesia with Propofol.?

Common side effects of total intravenous anaesthesia with Propofol. include Hypotension, Respiratory depression, Bradycardia, Injection site pain, Apnea, Propofol infusion syndrome (with prolonged high-dose infusion).

What does total intravenous anaesthesia with Propofol. target?

total intravenous anaesthesia with Propofol. targets GABA-A receptor and is a Intravenous sedative-hypnotic.

Related